Additional information
| Water Retention | None |
|---|---|
| Hepatotoxicity | Rare, but potential severe liver injury |
| Lab Test | Not specifically monitored through lab tests, focus is on clinical assessment |
| Strength | 60 mg |
| Also known as | Tomoxetine |
| Blood pressure | Can cause an increase in blood pressure and heart rate |
| Trade name | Strattera |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | N-methyl-3-phenyl-3-(o-tolyloxy)-propylamine |
| Formula | C17H21NO |
| Substance class | Selective norepinephrine reuptake inhibitor |
| Main action | Increases norepinephrine and dopamine levels in the prefrontal cortex |
| Half-life | Approximately 5 hours |
| Dosage (medical) | Typically starts at 40 mg per day for adults, adjusted as needed |
| Dosage (sports) | Not applicable as it is not used for enhancing athletic performance |
| Effects | Improves attention, reduces impulsivity and hyperactivity in ADHD |
| Side effects | Dry mouth, insomnia, decreased appetite, increased blood pressure and heart rate |
| Use in sports | None, as it is not anabolic or performance-enhancing |
| Manufacturer | Intas Pharmaceuticals |
Zimaks 400 Bilim
Extrifit Carni Liquid 120000 1000 ml EXTRIFIT
Norvacs 5 mg Pfizer
Pre-Competitive Cutting Cycle Ultima Pharmaceuticals
Tavanic 500 mg Sanofi
Choriomon 5000 IU IBSA
Alpha Pharma Astralean 0,4 mcg 50 Tabletten
FUCIDIN 500 mg Abdi Ibragim 




Reviews
There are no reviews yet.